High frequency of Q318X mutation in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Northeast Brazil;Alta freqüência da mutação Q318X em pacientes com hiperplasia adrenal congênita por deficiência da 21-hidroxilase no nordeste do Brasil

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 53, Issue 1, 2009, Pages 40-46

  Campos, Viviane C ^a   Pereira, Rossana M C ^a   Torres, Natália ^b   de Castro, Margaret ^b   Aguiar Oliveira, Manuel H ^a  

^a FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

21 hydroxylase deficiency; Adrenal hyperplasia; CYP21A microconversions

Indexed keywords

EID: 66149097418     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302009000100007     Document Type: Article

References (33)

1. Bongiovanni AM, Root AM. The adrenogenital syndrome. N Engl J Med. 1963;268:1283-9.
2. Speiser PW, Dupont J, Zhu D, Serrat J, Buegeleisen M, Tusie-Luna MT, et al. Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest. 1992;90:584-95.
3. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev. 2000;21(3):245-91.
4. White PC, Speiser PW. Congenital adrenal hyperplasia. N Engl J Med. 2003;349:776-88.
5. Riepe GF, Tatzel S, Sippell GW, Pleiss J, Krone N. Congenital Adrenal Hyperplasia: The Molecular Basis of 21-Hydroxylase in H-2aw18 Mice. Endocrinology. 2005;143:2563-74.
6. White PC, New MI, Dupont B. Struture of human steroid 21-hydroxylase genes. Proc Natl Acad Sci. 1986;83:5111-5.
7. Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS, et al. Human Gene Mutation Database (HGMD): 2003 Update. Hum. Mutat. 2003;21:577-81.
8. Wilson RC, Wei JQ, Cheng KC, Mercado AB, New MI. Rapid Deoxyribonucleic acid analysis by allele-specific polymerase chain reaction for detection of mutations in the 21-hydroxylase gene. J Clin Endocrinol Metab. 1995;80:1635-40.
9. Miller WL. Clinical review 54. Genetics, diagnosis, and management of 21-hydroxylase deficiency. J Clin Endocrinol Metab. 1994;78:241-6.
10. Araujo RS, Billerbeck AEC, Madureira G, Mendonça BB, Bachega TASS. Substitutions in the CYP21A2 promoter explain the simple virilizing form 21-hydroxylase deficiency in patients harbouring a P30L mutation. Clin Endocrinol. 2005;62:132-6.
11. Araujo RS, Mendonca BB, Barbosa AS, Lin CJ, Marcondes JAM, Billerbeck AEC, Bachega TASS. Microconversion between CYP21A2 and CYP21A1P promoter regions causes the nonclassical form of 21-Hydrxylase Defciency. J Clin Endocrinol Metab. 2007;92: 4028-34.
12. Nordenström A, Thilén A, Hagenfeldt L, Larsson A, Wedell A. Genotyping is a valuable diagnostic complement to neonatal screening for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab. 1999;84:1505-9.
13. Fitness J, Dixit N, Webster D, Torresani T, Pergolizzi R, Speiser PW, et al. Genotyping of CYP21, linked chromosome 6p markers, and a sexspecific gene in neonatal screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1999;84:960-6.
14. Torres N, Mello MP, Germano CMR, Elias LLK, Moreira AC, Castro M. Phenotype and genotype correlation of the microconversion from the CYP21A1P to the CYP21A2 gene in congenital adrenal hyperplasia. Braz J Med Biol Res. 2003;36:1311-8.
15. Bachega TASS, Billerbeck AEC, Madureira G, Marcondes JAM, Longui CA, Leite MV. Molecular genotyping in Brazilian patients with the classical and nonclassical forms of 21-hydroxylase deficiency. J Clin Endocrinol Metab. 1998;83:4416-9.
16. Toralles MBP. Deficiência de 21-hidroxilase (forma clássica) em indivíduos miscigenados da Bahia: Estudo familial clínico e molecular [Tese]. Salvador. Faculdade de Medicina da Universidade Federal da Bahia; 1999.
17. Paulino LC, Araujo M, Guerra JRG, Marini SHVL, De Mello MP. Mutation distribution and CYP21 / C4 locus variability in Brazilian families with the classical form of the 21-hydroxylase deficiency. Acta Paediatr. 1999;88:273-83.
18. Bachega TASS, Billerbeck AEC, Parente, EB, Lemos-Marini SHV, Baptista MTM, Mello MP, et al. Estudo multicêntrico de pacientes brasileiros com deficiência da 21-hidroxilase: correlação do genótipo com o fenótipo. Arq Bras Endocrinol Metab. 2004;48:697-704.
19. IBGE.gov.br [homepage on the internet]. Brasil: Instituto Brasileiro de Geografia e Estatística; [updated 2007/Jan/16]. Available from: http://www.ibge.gov.br/cidadesat/default.php.
20. Araujo M, Sanches MR, Suzuki LA, Guerra JG, Farah SB, Mello MP. Molecular analysis of CYP21 and C4 genes in Brazilian families with the classical form of steroid 21-hydroxylase deficiency. Braz J Med Biol Res. 1996;29:1-13.
21. Bachega TASS. Mutações no gene da 21-hidroxilase em pacientes com hiperplasia adrenal congênita por deficiência dehidroxilase, formas clássicas e não-clássicas [Tese]. São Paulo. Faculdade de Medicina da Universidade de São Paulo; 1998.
22. Bachega TASS, Billerbeck AEC, Madureira G, Arnhold IJP, Medeiros MA, Marcondes JAM, et al. Low frequency of CYP21B deletions in Brazilian patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum Hered. 1999;49:9-14.
23. Bachega TASS, Billerbeck AEC, Marcondes JAM, Madureira G, Arnhold IJP, Mendonça BB. Influence of different genotypes on 17-hydroxyprogesterone levels in patients with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin Endocrinol. 2000;52:601-7.
24. Billerbeck AEC, Bachega TASS, Frazzatto ET, Nishi MY, Goldberg AC, Marin MLC, et al. A novel missense mutation, GLY424SER, in Brazilian patients with 21-hydroxylase deficiency. J Clin Endocrinol Metab. 1999;84:2870-2.
25. Billerbeck AEC, Mendonça BB, Pinto EM, Madureira G, Arnhold IJP, Bachega TASS. Three novel mutations in CYP21 gene in Brazilian patients with the classical form of 21-hydroxylase deficiency due a founder effect. J Clin Endocrinol Metab. 2002;87:4314-7.
26. Witchel SF, Smith R, Crivellaro CE, Manna TD, Dichtchekenian V, Setian N, Damiani D. CYP21 mutations in Brazilian patients with 21-hydroxylase deficiency. Hum Genet. 2000;106:414-9.
27. Carrera P, Bordone L, Azzani T, Brunelli V, Garancini MP, Chiumello G, et al. Point mutations in Italian patients with classic, nonclassic and cryptic forms of steroid 21-hydroxylase deficiency. Hum Hered. 1996;98:662-5.
28. Dardis A, Bergada I, Bergada C, Rivarola M, Belgorosky A. Mutations of the steroid 21-hydroxylase gene in Argentinian population of 36 patients with classical congenital adrenal hyperplasia. J Pediatr Endocrinol Metab. 1997;10:55-61.
29. Ezquieta B, Oliver A, Gracia R, Gcedo PG. Analysis of steroid 21-hydroxylase gene mutations in the Spanish population. Hum Genet. 1995;6:198-204.
30. Mornet E, Crété P, Kuttenn F, Raux-Demay MC, Boué J, White PC. Distribution of deletions and seven point mutations on CYP21 genes in three clinical forms of steroid 21-hydroxylase deficiency. Am J Hum Genet. 1991;48:79-88.
31. Wilson RC, Mercado AB, Cheng KC, New MI. Steroid 21-Hydroxylase Deficiency: Genotype may not predict Phenotype. J Clin Endocrinol Metabolism. 1995;80:2322-9.
32. Kharrat M, Tardy V, M'Rad R, Maazoul F, Jemaa LB, Refai M, et al. Molecular genetic analysis of Tunisian patients with a classic form of 21-hydroxylase deficiency: identification of four novel mutations and high prevalence of Q318X mutation. J Clin Endocrinol Metab. 2004;89:368-74.
33. Dölzan V, Solyom J, Fekete G, Kovacs J, Rakosnikova V, Votava F, et al. Mutational spectrum of steroid 21-hydroxylase and the genotypephenotype association in Middle European patients with congenital adrenal hyperplasia. Eur J Endocrinology. 2005;153:99-106.